Your browser doesn't support javascript.
loading
The Controlling Nutritional Status (CONUT) Score and Prognosis in Malignant Tumors: A Systematic Review and Meta-Analysis.
Chen, Junhao; Song, Pan; Peng, Zhufeng; Liu, Zhenghuan; Yang, Luchen; Wang, Linchun; Zhou, Jing; Dong, Qiang.
Afiliação
  • Chen J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Song P; West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
  • Peng Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Liu Z; West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
  • Yang L; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wang L; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhou J; West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
  • Dong Q; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Nutr Cancer ; 74(9): 3146-3163, 2022.
Article em En | MEDLINE | ID: mdl-35382655
ABSTRACT
Increasing evidences indicate that the controlling nutritional status (CONUT) score is associated with cancer prognosis. This study was conducted to investigate the prognostic significance of pretreatment CONUT score on patients with various malignant tumors. The correlation between CONUT score and clinical outcomes of tumor patients were studied by electronic literature retrieval. Pooled hazard ratios (HR), odds ratios (OR) and 95% confidence intervals (95% CI) were calculated to clarify the conclusion. Subgroup analysis were conducted in line with cancer type, cancer stage, treatment, sample size and cut-off value. A total of 62 studies involving 25224 patients were included in this study. Pooled analysis showed that higher CONUT scores were associated with shorter overall survival (HR 1.62, 95% CI 1.45-1.79, p < 0.001), cancer-specific survival (HR 1.80, 95% CI 1.48-2.13, p < 0.001), progress/recurrence-free survival (HR 1.54, 95% CI 1.23-1.85, p < 0.001) and disease-free survival (HR 1.56, 95% CI 1.39-1.74, p < 0.001). In addition, high CONUT score was correlated to higher incidence of postoperative complications (OR 1.64, 95% CI 1.38-1.95, p < 0.001) and mortality (OR 4.22, 95% CI 2.22-8.02, p < 0.001). Consequently, the pretreatment CONUT score is a valuable indicator to predict the clinical outcomes of patients with various malignant tumors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Nutricional / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Nutricional / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article